Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (11822)	11/28/1997 1:54:00 PM
From: Night Trader	Read Replies (1) \| Respond to of 32384

Andrew, thanks for the info on Westergaard. After reading that I don't give them any credibility either. However it did raise some questions in my mind regarding investment bankers and Ligand. In particular the famous Robertson Stephen esimate of $14.55 earnings per share in 2006. What was their relationship with LGND at the time it was made? Estimates made for small companies are often absurdly optimistic even for one or two years out, let alone ten. Analysts too often factor in demand but ignore supply and competition. I still believe in the science and will continue to hold the stock but not without reservations.

To: Andrew H who wrote (11822)	11/28/1997 9:09:00 PM
From: Pluvia	Read Replies (2) \| Respond to of 32384

<<<Martin, while I agree that the market has difficulty evaluating development stage biotechs, Westergaard's view of the situation is terribly simplistic and appears prescient only in hindsight. When sitting on top of the next biotech rally, it will look completely nescient.>>> Andrew H., Greetings, I think you would do well to look at Westergaards historical performance. It is a complete sham. Try reviewing some of his picks of the week that he claims are "must own stocks". Many have fallen more than 50% some 80%. If he had taken his own advice on his stock picks during the last year It looks like he would not be in the investment advice business -- try asking him for his performance record. Expect a longwinded rationalization. A monkey throwing darts at the WSJ would clearly outperform Westergaard. Westergaard's company and other affilate companies are PAID to promote stocks, a question the SEC has called me about as I found some companiesa where he was paid in stock <according to the company's CEO>, which the SEC apparently frowns upon. Perhaps in a criminal way. I guess the bottom line is this -- I have reviewed Westergaards past rec's. Look hard at stocks Westergaard promotes, I found a very disturbing trend that looked like the stocks would rally a little then crash shortly after he began promoting them. I would like to know if he propmotes stocks while he or persons he knows feeds the market stock. The stock price trend I saw seemed to support that idea. Cheers Steve